Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Recruiting
Observational Study
Multiple Sclerosis
Multiple Sclerosis, Secondary Progressive
Multiple Sclerosis Relapse
Multiple Sclerosis, Relapsing-Remitting
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Shirley Ryan AbilityLab · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS)
* Able to ambulate overground
* Relapse free for at least 1 month
* Age ≥18 and ≤ 75 years
* Participants using dalfampridine will be eligible if taking the same daily dose for at…
Contacts